Alpha 2.0
Login Register
» Articles » PMID: 35321257

Systemic 9-valent Human Papillomavirus Vaccine for Recalcitrant Common Cutaneous Warts in Preparation for Renal Transplant

Overview
Journal JAAD Case Rep
Specialty Dermatology
Date 2022 Mar 24
PMID 35321257
Authors
W Austin Wyant
George W Burke
Tim Ioannides
Anna J Nichols
Affiliations
Soon will be listed here.
Citing Articles

Human papillomavirus infection-related cancer risk for kidney transplant recipients during adult life can be reduced by vaccination during childhood and adolescence.

Nailescu C, Shew M Front Pediatr. 2022; 10:1057454.

PMID: 36533243 PMC: 9749905. DOI: 10.3389/fped.2022.1057454.

References
1.
Ferguson S, Gallo E . Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult. JAAD Case Rep. 2017; 3(4):367-369. PMC: 5537385. DOI: 10.1016/j.jdcr.2017.05.007. View
2.
Nichols A, De Bedout V, Fayne R, Burke G, Kirsner R, Ioannides T . Systemic and intratumoral 9-valent human papillomavirus vaccine treatment for squamous cell carcinoma in situ in a renal transplant recipient. JAAD Case Rep. 2020; 6(4):289-291. PMC: 7109374. DOI: 10.1016/j.jdcr.2020.02.002. View
3.
DSouza G, Zins J . Severe Plantar Warts in an Immunocompromised Patient. N Engl J Med. 2017; 377(3):267. DOI: 10.1056/NEJMicm1616238. View
4.
Bencini P, Guida S, Cazzaniga S, Pellacani G, Galimberti M, Bencini M . Risk factors for recurrence after successful treatment of warts: the role of smoking habits. J Eur Acad Dermatol Venereol. 2016; 31(4):712-716. DOI: 10.1111/jdv.14086. View
5.
Kost Y, Deutsch A, Zhu T, Hulur I, Blasiak R . Vaccination against human papillomavirus is not associated with resolution of verruca vulgaris in immunocompetent 9- to 21-year olds. J Am Acad Dermatol. 2021; 87(1):250-252. DOI: 10.1016/j.jaad.2021.08.016. View